The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia

Pediatrics International

Volumn 47, Issue 6, 2005, Pages 676-680

  Cetin, Hasan ^a   Yalaz, Mehmet ^a   Akisu, Mete ^a   Hilmioglu, Suleyha ^a   Metin, Dilek ^a   Kultursay, Nilgun ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Candida; Newborn; Sepsis; Treatment

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN B LIPID COMPLEX; CREATININE; AMPHOTERICIN B; ANTIFUNGAL AGENT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CANDIDA; CONTROLLED STUDY; COST OF ILLNESS; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; ERADICATION THERAPY; GESTATIONAL AGE; HUMAN; HYPOKALEMIA; HYPONATREMIA; INCIDENCE; INFANT; LIVER TOXICITY; MAJOR CLINICAL STUDY; MORTALITY; NEPHROTOXICITY; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT; CANDIDIASIS; DRUG COMBINATION; FUNGEMIA; RETROSPECTIVE STUDY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG COMBINATIONS; FUNGEMIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644876295     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02135.x     Document Type: Article

References (30)

1. Ronnestad A, Abrahamsen TG, Gaustad P, Finne PH. Blood culture isolates during 6 years in tertiary neonatal intensive care unit. Scand. J. Infect. Dis. 1998 30 : 245 51.
2. Leibovitz E, Flidel-Rimon O, Juster-Reicher A et al. Sepsis at a neonatal intensive care unit: a four year retrospective study (1989-92). Isr. J. Med. Sci. 1997 33 : 734 8.
3. Koutouby A, Habibullah J. Neonatal sepsis in Dubai, United Arab Emirates. J. Trop. Pediatr. 1995 41 : 177 80.
4. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr. Infect. Dis. J. 1998 17 : 504 8.
5. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002 110 : 285 91.
6. Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001 107 : 61 6.
7. Cordero L, Sananes M, Ayers LW. Blood stream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect. Control Hosp. Epidemiol. 1999 20 : 242 6.
8. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low birth weight infants: clinical manifestations and epidemiology. Pediatrics 1984 73 : 144 52.
9. Benjamin DK, Ross K, McKinney RE, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida Parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000 106 : 712 18.
10. Oral R, Akisu M, Kultursay N, Vardar F, Tansug N. Neonatal Klebsiella pneumonia sepsis and imipenem/cilastatin. Indian J. Pediatr. 1998 65 : 121 9.
11. Pera A, Byun A, Gribar S, Schwartz R, Kumar D, Parimi P. Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams. J. Perinatol. 2002 22 : 204 8.
12. Jarvis WR. The epidemiology of colonization. Infect. Control Hosp. Epidemiol. 1996 17 : 42 52.
13. Hageman JR, Stenske J, Keuler H, Randall E. Candida colonization and infection in very low birthweight infants: clinical manifestations and epidemiology. J. Perinatol. 1986 6 : 251 4.
14. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in very low birthweight infants. Pediatrics 1986 78 : 225 32.
15. Rowen JL, Rench MA, Kozinetz CA, Adams JM, Baker CJ. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birthweight neonates. J. Pediatr. 1994 124 : 789 94.
16. Shattuck KE, Cochran CK, Zabransky RJ, Pasarell L, Davis JC, Mallowy MH. Colonization and infection associated with Malassezia and Candida species in a neonatal unit. J. Hosp. Infect. 1996 34 : 123 9.
17. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr. Infect. Dis. J. 1998 17 : 146 8.
18. Walsh TJ, Seibel NL, Arndt C et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr. Infect. Dis. J. 1999 18 : 702 8.
19. Reicher AJ, Leibovitz E, Linder N et al. Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight Infants. Infection 2000 28 : 223 6.
20. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002 109 : 34 9.
21. Tirodker UH, Nataro JP, Smith S, LasCasas L, Fairchild KD. Detection of fungemia by polymerase chain reaction in critically ill neonates and children. J. Perinatol. 2003 23 : 117 22.
22. Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J. Trop. Pediatr. 1998 44 : 104 8.
23. Driessen M, Ellis JB, Cooper PA et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr. Infect. Dis. J. 1996 15 : 1107 12.
24. Wainer S, Cooper PA, Gous H, Akierman A. Prospective study of fluconazole therapy in systemic fungal infection. Pediatr. Infect. Dis. J. 1997 16 : 763 7.
25. Saiman L, Ludington E, Dawson JD et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. Pediatr. Infect. Dis. J. 2000 19 : 319 24.
26. Bor O, Tekin N, Kiraz N, Aksit MA. Candidemia in neonatal intensive care unit. Turkish J. Infect. 2001 15 : 1 4.
27. Friedman S, Richardson SE, Jacobs SE, O'Brien K. Systemic Candida infections in extremly low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr. Infect. Dis. J. 2000 19 : 499 504.
28. Adler-Shohet F, Waskin H, Lieberman JM. Amphotericin B lipid complex for neonatal invasive candidiasis. Arch. Dis. Child. Fetal Neonatal Ed. 2001 84 : F131 3.
29. Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J. Chemother. 2000 12 : 463 70.
30. Linder N, Klinger G, Shalit I et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J. Antimicrob. Chemother. 2003 52 : 663 7.